Reputation and power :: organizational image and pharmaceutical regulation at the FDA /
The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organ...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Princeton :
Princeton University Press,
©2010.
|
| Schriftenreihe: | Princeton studies in American politics.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industr. |
| Beschreibung: | 1 online resource (xx, 802 pages) : illustrations, map |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781400835119 1400835119 9786612639487 6612639482 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn655342133 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr mnu---unuuu | ||
| 008 | 100812s2010 njuab ob 001 0 eng d | ||
| 010 | |z 2009044230 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d IDEBK |d EBLCP |d YDXCP |d E7B |d OCLCQ |d CDX |d OSU |d OCLCQ |d WAU |d MERUC |d OCLCQ |d DEBSZ |d OCLCA |d JSTOR |d OCLCF |d OCLCQ |d OCLCO |d P@U |d OCLCA |d COO |d OCLCQ |d CUS |d OCLCQ |d LOA |d JBG |d EZ9 |d OCLCQ |d OCLCO |d YDX |d AGLDB |d MOR |d PIFAG |d ZCU |d OCLCO |d OTZ |d OCLCO |d OCLCQ |d IOG |d OCLCO |d OCLCA |d U3W |d KIJ |d STF |d WRM |d VNS |d OCLCO |d VTS |d OCLCO |d KSU |d ICG |d NRAMU |d VT2 |d AU@ |d OCLCO |d WYU |d OCLCO |d LVT |d OCLCO |d S9I |d U3G |d DKC |d OCLCQ |d M8D |d UKAHL |d ADU |d OCLCQ |d OCLCO |d UKCRE |d MM9 |d VLY |d OCLCQ |d OCLCO |d TUHNV |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ |d EZC | ||
| 019 | |a 649913124 |a 651130204 |a 960200374 |a 961620977 |a 962624285 |a 974575240 |a 974613425 |a 984577270 |a 988490472 |a 992104134 |a 992313762 |a 994955087 |a 1018009678 |a 1034905400 |a 1037936268 |a 1038649460 |a 1041788545 |a 1045527125 |a 1048335891 |a 1055328304 |a 1055860547 |a 1064777623 |a 1066425205 |a 1113362478 |a 1119031475 |a 1121002637 |a 1153511599 |a 1158011418 |a 1162003114 |a 1178723404 |a 1181901198 |a 1184510099 |a 1190681231 |a 1228607226 |a 1235830551 |a 1240509940 |a 1241804851 |a 1243573084 |a 1297040372 | ||
| 020 | |a 9781400835119 |q (electronic bk.) | ||
| 020 | |a 1400835119 |q (electronic bk.) | ||
| 020 | |z 9780691141794 |q (hardcover ; |q alk. paper) | ||
| 020 | |z 0691141797 |q (hardcover ; |q alk. paper) | ||
| 020 | |z 9780691141800 |q (pbk. ; |q alk. paper) | ||
| 020 | |z 0691141800 |q (pbk. ; |q alk. paper) | ||
| 020 | |a 9786612639487 | ||
| 020 | |a 6612639482 | ||
| 024 | 8 | |a 9786612639487 | |
| 035 | |a (OCoLC)655342133 |z (OCoLC)649913124 |z (OCoLC)651130204 |z (OCoLC)960200374 |z (OCoLC)961620977 |z (OCoLC)962624285 |z (OCoLC)974575240 |z (OCoLC)974613425 |z (OCoLC)984577270 |z (OCoLC)988490472 |z (OCoLC)992104134 |z (OCoLC)992313762 |z (OCoLC)994955087 |z (OCoLC)1018009678 |z (OCoLC)1034905400 |z (OCoLC)1037936268 |z (OCoLC)1038649460 |z (OCoLC)1041788545 |z (OCoLC)1045527125 |z (OCoLC)1048335891 |z (OCoLC)1055328304 |z (OCoLC)1055860547 |z (OCoLC)1064777623 |z (OCoLC)1066425205 |z (OCoLC)1113362478 |z (OCoLC)1119031475 |z (OCoLC)1121002637 |z (OCoLC)1153511599 |z (OCoLC)1158011418 |z (OCoLC)1162003114 |z (OCoLC)1178723404 |z (OCoLC)1181901198 |z (OCoLC)1184510099 |z (OCoLC)1190681231 |z (OCoLC)1228607226 |z (OCoLC)1235830551 |z (OCoLC)1240509940 |z (OCoLC)1241804851 |z (OCoLC)1243573084 |z (OCoLC)1297040372 | ||
| 037 | |a 263948 |b MIL | ||
| 037 | |a 22573/cttwfbz |b JSTOR | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RA401.A3 |b C37 2010eb | |
| 060 | 4 | |a 2010 G-272 | |
| 060 | 4 | |a QV 771 | |
| 072 | 7 | |a MED |x 003000 |2 bisacsh | |
| 072 | 7 | |a MED071000 |2 bisacsh | |
| 072 | 7 | |a POL028000 |2 bisacsh | |
| 072 | 7 | |a HIS036000 |2 bisacsh | |
| 082 | 7 | |a 362.17/82 |2 22 | |
| 084 | |a 44.14 |2 bcl | ||
| 049 | |a MAIN | ||
| 100 | 1 | |a Carpenter, Daniel P., |d 1967- |e author. |1 https://id.oclc.org/worldcat/entity/E39PCjDpyJdFrMqPYGMwJXC38K |0 http://id.loc.gov/authorities/names/n2001109147 | |
| 245 | 1 | 0 | |a Reputation and power : |b organizational image and pharmaceutical regulation at the FDA / |c Daniel Carpenter. |
| 260 | |a Princeton : |b Princeton University Press, |c ©2010. | ||
| 300 | |a 1 online resource (xx, 802 pages) : |b illustrations, map | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 380 | |a Bibliography | ||
| 490 | 1 | |a Princeton studies in American politics : historical, international, and comparative perspectives | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |g Introduction: |t The gatekeeper -- |t Reputation and regulatory power -- |t Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath -- |t The ambiguous emergence of American pharmaceutical regulation, 1944-1961 -- |t Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 -- |t Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 -- |t Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 -- |t Reputation and the organizational politics of new drug review -- |t The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite -- |t The other side of the gate : reputation, power, and post-market regulation -- |t The détenté of firm and regulator -- |t American pharmaceutical regulations in international context : audiences, comparisons, and dependencies -- |g Conclusion: |t A reputation in brief. |
| 520 | |a The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industr. | ||
| 588 | 0 | |a Print version record. | |
| 546 | |a English. | ||
| 610 | 1 | 0 | |a United States. |b Food and Drug Administration. |0 http://id.loc.gov/authorities/names/n80126147 |
| 610 | 1 | 2 | |a United States |b Food and Drug Administration |
| 610 | 1 | 7 | |a United States. |b Food and Drug Administration |2 fast |
| 650 | 0 | |a Pharmaceutical policy |z United States. | |
| 650 | 0 | |a Drugs |x Research |z United States. | |
| 650 | 6 | |a Médicaments |x Politique gouvernementale |z États-Unis. | |
| 650 | 6 | |a Médicaments |x Recherche |z États-Unis. | |
| 650 | 7 | |a MEDICAL |x Allied Health Services |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drugs |x Research |2 fast | |
| 650 | 7 | |a Pharmaceutical policy |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 655 | 7 | |a dissertations. |2 aat | |
| 655 | 7 | |a Academic theses |2 fast | |
| 655 | 7 | |a Academic theses. |2 lcgft |0 http://id.loc.gov/authorities/genreForms/gf2014026039 | |
| 655 | 7 | |a Thèses et écrits académiques. |2 rvmgf | |
| 758 | |i has work: |a Reputation and power (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGjcdvqvTJ4XxcjbcvbXBd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Carpenter, Daniel P., 1967- |t Reputation and power. |d Princeton, N.J. : Princeton University Press, ©2010 |z 9780691141800 |w (DLC) 2009044230 |w (OCoLC)463970952 |
| 830 | 0 | |a Princeton studies in American politics. |0 http://id.loc.gov/authorities/names/n92061567 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=329845 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH26387718 | ||
| 938 | |a Coutts Information Services |b COUT |n 13832499 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL540270 | ||
| 938 | |a ebrary |b EBRY |n ebr10394772 | ||
| 938 | |a EBSCOhost |b EBSC |n 329845 | ||
| 938 | |a Project MUSE |b MUSE |n muse36704 | ||
| 938 | |a YBP Library Services |b YANK |n 3330955 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn655342133 |
|---|---|
| _version_ | 1816881735700316160 |
| adam_text | |
| any_adam_object | |
| author | Carpenter, Daniel P., 1967- |
| author_GND | http://id.loc.gov/authorities/names/n2001109147 |
| author_facet | Carpenter, Daniel P., 1967- |
| author_role | aut |
| author_sort | Carpenter, Daniel P., 1967- |
| author_variant | d p c dp dpc |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RA401 |
| callnumber-raw | RA401.A3 C37 2010eb |
| callnumber-search | RA401.A3 C37 2010eb |
| callnumber-sort | RA 3401 A3 C37 42010EB |
| callnumber-subject | RA - Public Medicine |
| collection | ZDB-4-EBA |
| contents | The gatekeeper -- Reputation and regulatory power -- Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath -- The ambiguous emergence of American pharmaceutical regulation, 1944-1961 -- Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 -- Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 -- Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 -- Reputation and the organizational politics of new drug review -- The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite -- The other side of the gate : reputation, power, and post-market regulation -- The détenté of firm and regulator -- American pharmaceutical regulations in international context : audiences, comparisons, and dependencies -- A reputation in brief. |
| ctrlnum | (OCoLC)655342133 |
| dewey-full | 362.17/82 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.17/82 |
| dewey-search | 362.17/82 |
| dewey-sort | 3362.17 282 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07217cam a2200925 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn655342133</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr mnu---unuuu</controlfield><controlfield tag="008">100812s2010 njuab ob 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2009044230</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">IDEBK</subfield><subfield code="d">EBLCP</subfield><subfield code="d">YDXCP</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">CDX</subfield><subfield code="d">OSU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WAU</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">JSTOR</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">P@U</subfield><subfield code="d">OCLCA</subfield><subfield code="d">COO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">CUS</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">LOA</subfield><subfield code="d">JBG</subfield><subfield code="d">EZ9</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDX</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OTZ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">IOG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">KIJ</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VTS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">KSU</subfield><subfield code="d">ICG</subfield><subfield code="d">NRAMU</subfield><subfield code="d">VT2</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">LVT</subfield><subfield code="d">OCLCO</subfield><subfield code="d">S9I</subfield><subfield code="d">U3G</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">M8D</subfield><subfield code="d">UKAHL</subfield><subfield code="d">ADU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UKCRE</subfield><subfield code="d">MM9</subfield><subfield code="d">VLY</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TUHNV</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EZC</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">649913124</subfield><subfield code="a">651130204</subfield><subfield code="a">960200374</subfield><subfield code="a">961620977</subfield><subfield code="a">962624285</subfield><subfield code="a">974575240</subfield><subfield code="a">974613425</subfield><subfield code="a">984577270</subfield><subfield code="a">988490472</subfield><subfield code="a">992104134</subfield><subfield code="a">992313762</subfield><subfield code="a">994955087</subfield><subfield code="a">1018009678</subfield><subfield code="a">1034905400</subfield><subfield code="a">1037936268</subfield><subfield code="a">1038649460</subfield><subfield code="a">1041788545</subfield><subfield code="a">1045527125</subfield><subfield code="a">1048335891</subfield><subfield code="a">1055328304</subfield><subfield code="a">1055860547</subfield><subfield code="a">1064777623</subfield><subfield code="a">1066425205</subfield><subfield code="a">1113362478</subfield><subfield code="a">1119031475</subfield><subfield code="a">1121002637</subfield><subfield code="a">1153511599</subfield><subfield code="a">1158011418</subfield><subfield code="a">1162003114</subfield><subfield code="a">1178723404</subfield><subfield code="a">1181901198</subfield><subfield code="a">1184510099</subfield><subfield code="a">1190681231</subfield><subfield code="a">1228607226</subfield><subfield code="a">1235830551</subfield><subfield code="a">1240509940</subfield><subfield code="a">1241804851</subfield><subfield code="a">1243573084</subfield><subfield code="a">1297040372</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781400835119</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1400835119</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780691141794</subfield><subfield code="q">(hardcover ;</subfield><subfield code="q">alk. paper)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0691141797</subfield><subfield code="q">(hardcover ;</subfield><subfield code="q">alk. paper)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780691141800</subfield><subfield code="q">(pbk. ;</subfield><subfield code="q">alk. paper)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0691141800</subfield><subfield code="q">(pbk. ;</subfield><subfield code="q">alk. paper)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786612639487</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6612639482</subfield></datafield><datafield tag="024" ind1="8" ind2=" "><subfield code="a">9786612639487</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)655342133</subfield><subfield code="z">(OCoLC)649913124</subfield><subfield code="z">(OCoLC)651130204</subfield><subfield code="z">(OCoLC)960200374</subfield><subfield code="z">(OCoLC)961620977</subfield><subfield code="z">(OCoLC)962624285</subfield><subfield code="z">(OCoLC)974575240</subfield><subfield code="z">(OCoLC)974613425</subfield><subfield code="z">(OCoLC)984577270</subfield><subfield code="z">(OCoLC)988490472</subfield><subfield code="z">(OCoLC)992104134</subfield><subfield code="z">(OCoLC)992313762</subfield><subfield code="z">(OCoLC)994955087</subfield><subfield code="z">(OCoLC)1018009678</subfield><subfield code="z">(OCoLC)1034905400</subfield><subfield code="z">(OCoLC)1037936268</subfield><subfield code="z">(OCoLC)1038649460</subfield><subfield code="z">(OCoLC)1041788545</subfield><subfield code="z">(OCoLC)1045527125</subfield><subfield code="z">(OCoLC)1048335891</subfield><subfield code="z">(OCoLC)1055328304</subfield><subfield code="z">(OCoLC)1055860547</subfield><subfield code="z">(OCoLC)1064777623</subfield><subfield code="z">(OCoLC)1066425205</subfield><subfield code="z">(OCoLC)1113362478</subfield><subfield code="z">(OCoLC)1119031475</subfield><subfield code="z">(OCoLC)1121002637</subfield><subfield code="z">(OCoLC)1153511599</subfield><subfield code="z">(OCoLC)1158011418</subfield><subfield code="z">(OCoLC)1162003114</subfield><subfield code="z">(OCoLC)1178723404</subfield><subfield code="z">(OCoLC)1181901198</subfield><subfield code="z">(OCoLC)1184510099</subfield><subfield code="z">(OCoLC)1190681231</subfield><subfield code="z">(OCoLC)1228607226</subfield><subfield code="z">(OCoLC)1235830551</subfield><subfield code="z">(OCoLC)1240509940</subfield><subfield code="z">(OCoLC)1241804851</subfield><subfield code="z">(OCoLC)1243573084</subfield><subfield code="z">(OCoLC)1297040372</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">263948</subfield><subfield code="b">MIL</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">22573/cttwfbz</subfield><subfield code="b">JSTOR</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA401.A3</subfield><subfield code="b">C37 2010eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2010 G-272</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 771</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">003000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">POL028000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HIS036000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">362.17/82</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.14</subfield><subfield code="2">bcl</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Carpenter, Daniel P.,</subfield><subfield code="d">1967-</subfield><subfield code="e">author.</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjDpyJdFrMqPYGMwJXC38K</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2001109147</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Reputation and power :</subfield><subfield code="b">organizational image and pharmaceutical regulation at the FDA /</subfield><subfield code="c">Daniel Carpenter.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Princeton :</subfield><subfield code="b">Princeton University Press,</subfield><subfield code="c">©2010.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xx, 802 pages) :</subfield><subfield code="b">illustrations, map</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="380" ind1=" " ind2=" "><subfield code="a">Bibliography</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Princeton studies in American politics : historical, international, and comparative perspectives</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="g">Introduction:</subfield><subfield code="t">The gatekeeper --</subfield><subfield code="t">Reputation and regulatory power --</subfield><subfield code="t">Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath --</subfield><subfield code="t">The ambiguous emergence of American pharmaceutical regulation, 1944-1961 --</subfield><subfield code="t">Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 --</subfield><subfield code="t">Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 --</subfield><subfield code="t">Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 --</subfield><subfield code="t">Reputation and the organizational politics of new drug review --</subfield><subfield code="t">The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite --</subfield><subfield code="t">The other side of the gate : reputation, power, and post-market regulation --</subfield><subfield code="t">The détenté of firm and regulator --</subfield><subfield code="t">American pharmaceutical regulations in international context : audiences, comparisons, and dependencies --</subfield><subfield code="g">Conclusion:</subfield><subfield code="t">A reputation in brief.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industr.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="610" ind1="1" ind2="0"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n80126147</subfield></datafield><datafield tag="610" ind1="1" ind2="2"><subfield code="a">United States</subfield><subfield code="b">Food and Drug Administration</subfield></datafield><datafield tag="610" ind1="1" ind2="7"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Politique gouvernementale</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Recherche</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Allied Health Services</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">dissertations.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Academic theses</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Academic theses.</subfield><subfield code="2">lcgft</subfield><subfield code="0">http://id.loc.gov/authorities/genreForms/gf2014026039</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Thèses et écrits académiques.</subfield><subfield code="2">rvmgf</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Reputation and power (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGjcdvqvTJ4XxcjbcvbXBd</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Carpenter, Daniel P., 1967-</subfield><subfield code="t">Reputation and power.</subfield><subfield code="d">Princeton, N.J. : Princeton University Press, ©2010</subfield><subfield code="z">9780691141800</subfield><subfield code="w">(DLC) 2009044230</subfield><subfield code="w">(OCoLC)463970952</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Princeton studies in American politics.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n92061567</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=329845</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH26387718</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">13832499</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL540270</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10394772</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">329845</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Project MUSE</subfield><subfield code="b">MUSE</subfield><subfield code="n">muse36704</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3330955</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | dissertations. aat Academic theses fast Academic theses. lcgft http://id.loc.gov/authorities/genreForms/gf2014026039 Thèses et écrits académiques. rvmgf |
| genre_facet | dissertations. Academic theses Academic theses. Thèses et écrits académiques. |
| geographic | United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocn655342133 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:17:26Z |
| institution | BVB |
| isbn | 9781400835119 1400835119 9786612639487 6612639482 |
| language | English |
| oclc_num | 655342133 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xx, 802 pages) : illustrations, map |
| psigel | ZDB-4-EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Princeton University Press, |
| record_format | marc |
| series | Princeton studies in American politics. |
| series2 | Princeton studies in American politics : historical, international, and comparative perspectives |
| spelling | Carpenter, Daniel P., 1967- author. https://id.oclc.org/worldcat/entity/E39PCjDpyJdFrMqPYGMwJXC38K http://id.loc.gov/authorities/names/n2001109147 Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter. Princeton : Princeton University Press, ©2010. 1 online resource (xx, 802 pages) : illustrations, map text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda Bibliography Princeton studies in American politics : historical, international, and comparative perspectives Includes bibliographical references and index. Introduction: The gatekeeper -- Reputation and regulatory power -- Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath -- The ambiguous emergence of American pharmaceutical regulation, 1944-1961 -- Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 -- Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 -- Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 -- Reputation and the organizational politics of new drug review -- The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite -- The other side of the gate : reputation, power, and post-market regulation -- The détenté of firm and regulator -- American pharmaceutical regulations in international context : audiences, comparisons, and dependencies -- Conclusion: A reputation in brief. The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industr. Print version record. English. United States. Food and Drug Administration. http://id.loc.gov/authorities/names/n80126147 United States Food and Drug Administration United States. Food and Drug Administration fast Pharmaceutical policy United States. Drugs Research United States. Médicaments Politique gouvernementale États-Unis. Médicaments Recherche États-Unis. MEDICAL Allied Health Services General. bisacsh MEDICAL Pharmacology. bisacsh Drugs Research fast Pharmaceutical policy fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq dissertations. aat Academic theses fast Academic theses. lcgft http://id.loc.gov/authorities/genreForms/gf2014026039 Thèses et écrits académiques. rvmgf has work: Reputation and power (Text) https://id.oclc.org/worldcat/entity/E39PCGjcdvqvTJ4XxcjbcvbXBd https://id.oclc.org/worldcat/ontology/hasWork Print version: Carpenter, Daniel P., 1967- Reputation and power. Princeton, N.J. : Princeton University Press, ©2010 9780691141800 (DLC) 2009044230 (OCoLC)463970952 Princeton studies in American politics. http://id.loc.gov/authorities/names/n92061567 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=329845 Volltext |
| spellingShingle | Carpenter, Daniel P., 1967- Reputation and power : organizational image and pharmaceutical regulation at the FDA / Princeton studies in American politics. The gatekeeper -- Reputation and regulatory power -- Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath -- The ambiguous emergence of American pharmaceutical regulation, 1944-1961 -- Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 -- Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 -- Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 -- Reputation and the organizational politics of new drug review -- The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite -- The other side of the gate : reputation, power, and post-market regulation -- The détenté of firm and regulator -- American pharmaceutical regulations in international context : audiences, comparisons, and dependencies -- A reputation in brief. United States. Food and Drug Administration. http://id.loc.gov/authorities/names/n80126147 United States Food and Drug Administration United States. Food and Drug Administration fast Pharmaceutical policy United States. Drugs Research United States. Médicaments Politique gouvernementale États-Unis. Médicaments Recherche États-Unis. MEDICAL Allied Health Services General. bisacsh MEDICAL Pharmacology. bisacsh Drugs Research fast Pharmaceutical policy fast |
| subject_GND | http://id.loc.gov/authorities/names/n80126147 http://id.loc.gov/authorities/genreForms/gf2014026039 |
| title | Reputation and power : organizational image and pharmaceutical regulation at the FDA / |
| title_alt | The gatekeeper -- Reputation and regulatory power -- Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath -- The ambiguous emergence of American pharmaceutical regulation, 1944-1961 -- Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966 -- Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986 -- Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992 -- Reputation and the organizational politics of new drug review -- The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite -- The other side of the gate : reputation, power, and post-market regulation -- The détenté of firm and regulator -- American pharmaceutical regulations in international context : audiences, comparisons, and dependencies -- A reputation in brief. |
| title_auth | Reputation and power : organizational image and pharmaceutical regulation at the FDA / |
| title_exact_search | Reputation and power : organizational image and pharmaceutical regulation at the FDA / |
| title_full | Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter. |
| title_fullStr | Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter. |
| title_full_unstemmed | Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter. |
| title_short | Reputation and power : |
| title_sort | reputation and power organizational image and pharmaceutical regulation at the fda |
| title_sub | organizational image and pharmaceutical regulation at the FDA / |
| topic | United States. Food and Drug Administration. http://id.loc.gov/authorities/names/n80126147 United States Food and Drug Administration United States. Food and Drug Administration fast Pharmaceutical policy United States. Drugs Research United States. Médicaments Politique gouvernementale États-Unis. Médicaments Recherche États-Unis. MEDICAL Allied Health Services General. bisacsh MEDICAL Pharmacology. bisacsh Drugs Research fast Pharmaceutical policy fast |
| topic_facet | United States. Food and Drug Administration. United States Food and Drug Administration United States. Food and Drug Administration Pharmaceutical policy United States. Drugs Research United States. Médicaments Politique gouvernementale États-Unis. Médicaments Recherche États-Unis. MEDICAL Allied Health Services General. MEDICAL Pharmacology. Drugs Research Pharmaceutical policy United States dissertations. Academic theses Academic theses. Thèses et écrits académiques. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=329845 |
| work_keys_str_mv | AT carpenterdanielp reputationandpowerorganizationalimageandpharmaceuticalregulationatthefda |